ANI Pharmaceuticals Inc (ANIP): R&D Expense
$51.66M
Year ended 2025-12-31
$49.91M
Trailing 12 months to 2026-06-30
+32.3%
3-year compound annual growth
+26.4%
5-year compound annual growth
+33.5%
10-year compound annual growth
| Period ended | R&D Expense | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $51.66M | +15.9% | 2026-02-27, From 2025-01-01 |
| 2024-12-31 | $44.58M | +30.0% | 2026-02-27, From 2024-01-01 |
| 2023-12-31 | $34.29M | +53.6% | 2026-02-27, From 2023-01-01 |
| 2022-12-31 | $22.32M | +96.3% | 2025-02-28, From 2022-01-01 |
| 2021-12-31 | $11.37M | -28.9% | 2024-02-29, From 2021-01-01 |
| 2020-12-31 | $16.00M | -19.2% | 2023-03-09, From 2020-01-01 |
| 2019-12-31 | $19.81M | +28.7% | 2022-03-15, From 2019-01-01 |
| 2018-12-31 | $15.39M | +69.7% | 2021-03-11, From 2018-01-01 |
| 2017-12-31 | $9.07M | +212.1% | 2020-02-27, From 2017-01-01 |
| 2016-12-31 | $2.91M | +1.1% | 2019-02-27, From 2016-01-01 |
| 2015-12-31 | $2.87M | +7.3% | 2018-02-27, From 2015-01-01 |
| 2014-12-31 | $2.68M | +56.4% | 2017-03-02, From 2014-01-01 |
| 2013-12-31 | $1.71M | +47.8% | 2016-02-23, From 2013-01-01 |
| 2012-12-31 | $1.16M | -97.4% | 2014-02-28, From 2012-01-01 |
| 2011-12-31 | $44.18M | +11.3% | 2013-02-28, From 2011-01-01 |
| 2010-12-31 | $39.71M | +190.2% | 2013-02-28, From 2010-01-01 |
| 2009-12-31 | $13.68M | n/a | 2012-03-13, From 2009-01-01 |
R&D Expense at similar companies
| Company | Year ended | R&D Expense | Change YoY |
|---|---|---|---|
| ANI Pharmaceuticals Inc (ANIP) | 2025-12-31 | $51.66M | +15.9% |
| Harmony Biosciences Holdings, Inc. (HRMY) | 2025-12-31 | $189.59M | +30.0% |
| Arrowhead Pharmaceuticals, Inc. (ARWR) | 2025-09-30 | $607.16M | +20.0% |
| Ionis Pharmaceuticals Inc (IONS) | 2025-12-31 | $915.62M | +1.6% |
| Madrigal Pharmaceuticals, Inc. (MDGL) | 2025-12-31 | $388.52M | +64.1% |
| Collegium Pharmaceutical, Inc (COLL) | 2024-12-31 | $0 | n/a |
| Corcept Therapeutics Inc (CORT) | 2025-12-31 | $254.91M | +3.2% |
| Emergent BioSolutions Inc. (EBS) | 2025-12-31 | $53.20M | -24.8% |
| Acadia Pharmaceuticals Inc (ACAD) | 2025-12-31 | $328.80M | +8.4% |
Compare ANIP, HRMY, ARWR, IONS side by side · Screen every company in Pharmaceutical Preparations ↗